Drug Type ASO |
Synonyms ION-269 |
Target |
Action inhibitors |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | United States | 20 Dec 2024 | |
Alzheimer Disease | Phase 1 | Spain | 20 Dec 2024 | |
Down Syndrome | Phase 1 | United States | 20 Dec 2024 | |
Down Syndrome | Phase 1 | Spain | 20 Dec 2024 |